ICICI Prudential Nifty Pharma Index Fund - Growth vs ICICI Prudential Nifty PSU Bond Plus SDL Sep 2027 40:60 Index Fund - Direct Plan Growth
Side-by-side comparison of NAV, returns, expense ratio and star rating.
TopFund Analysis
ICICI Prudential Nifty Pharma Index Fund - Growth appears stronger in terms of returns, boasting a 1-year return of 24.16% and a 3-year CAGR of 20.83%, compared to ICICI Prudential Nifty PSU Bond Plus SDL Sep 2027 40:60 Index Fund - Direct Plan Growth, which has a 1-year return of 5.4% and a 3-year CAGR of 7.39%. However, the latter fund has a significantly lower expense ratio of 0.2% and a higher AUM of ₹7771 Cr, indicating better cost efficiency and investor confidence. Investors should weigh the higher potential returns of the Pharma Index Fund against the lower costs and stability of the PSU Bond Index Fund.
ICICI Prudential Nifty Pharma Index Fund - Growth
ICICI Prudential Mutual Fund
★★★★★
Other · Index Funds
ICICI Prudential Nifty PSU Bond Plus SDL Sep 2027 40:60 Index Fund - Direct Plan Growth
ICICI Prudential Mutual Fund
★★★★★
Other · Index Funds
| Metric | ICICI Prudential Nifty... | ICICI Prudential Nifty... |
|---|---|---|
| NAV | ₹21.42 | ₹13.49 |
| Star Rating | ★★ | ★★★★★ |
| Expense Ratio | 0.51% | 0.2% |
| AUM | ₹163 Cr | ₹7,771 Cr |
| 1M Return | +10.68% | +0.48% |
| 3M Return | +7.56% | +0.93% |
| 6M Return | +13.89% | +3.13% |
| 1Y Return | +24.16% | +5.4% |
| 3Y CAGR | +20.83% | +7.39% |
| 5Y CAGR | — | +6.1% |
| Risk Level | — | — |
| Fund Manager | Nishit Patel | Anuj Tagra |